PTP News 62.16 Platinum Underwriters Holdings Ltd (PTP)

New Post Public Reply Private Reply Replies (0) Message Board

Apr 20, 2014 at 12:19 PM

Platinum Underwriters Holdings Ltd (PTP) 62.16 $PTP

Platinum Underwriters Holdings, Ltd. Reports First Quarter 2014 Financial Results
PR Newswire - Wed Apr 16, 3:00PM CDT
Platinum Underwriters Holdings, Ltd. (NYSE: PTP) today reported net income of $63.7 million and diluted earnings per common share of $2.27 for the quarter ended March 31, 2014.

3 Hot Insurers Expecting Earnings Beats - Earnings ESP
Zacks Equity Research - Zacks Investment Research - Wed Apr 16, 11:58AM CDT
insurers are aggressively seeking to take advantage of the moderate catastrophe period.

Allied World: A Strong Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 15, 3:35PM CDT
Zacks Investment Research upgraded Allied World Assurance Company Holdings, AGto a Zacks Rank #1 (Strong Buy) on April 15, 2014.

Why Earnings Season Could Be Great for Platinum Underwriters Holdings (PTP) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 15, 7:37AM CDT
Platinum Underwriters Holdings has been witnessing a significant price rise in the past month with a positive momentum in the earnings estimate front

3 Stocks Spiking on Big Volume
at The Street - Tue Apr 15, 7:20AM CDT
Often when above-average volume moves into an equity, it precedes a large spike in volatility.

Updated Research Report on Tower Group - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 10, 3:55PM CDT
Tower Group is facing a number of negative issues. These include mounting losses, reserve shortfall and job cuts.

Platinum Underwriters: A Strong Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 10, 8:40AM CDT
Zacks Investment Research upgraded Platinum Underwriters Holdings Ltd. to a Zacks Rank #1 (Strong Buy) on April 10, 2014.

Why Platinum Underwriters Holdings (PTP) is Poised to Beat Earnings Estimates (Again) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 10, 7:59AM CDT
Platinum Underwriters Holdings has been witnessing a significant price rise in the past month with a positive momentum in the earnings estimate front

Alleghany's Earnings Lag, Revs Beat Ests - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 9:00AM CST
Alleghany's operating earnings of $6.99 per share in the fourth quarter of 2013 lagged the Zacks Consensus Estimate but rebounded from the year-ago quarter's loss of $5.40 per share.

Earnings at First American Financial Beat Ests, Down Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 18, 8:40AM CST
First American Financial Corporation???s fourth-quarter 2013 operating earnings of 51 cents per share lagged the Zacks Consensus Estimate by a penny but plunged 37% year over year.

Ranking Our 5 Favorite Industries
David Hanson and Matt Koppenheffer, The Motley Fool - Motley Fool - Sat Feb 15, 5:00AM CST
Within the financial sector, there are banks, insurance companies, REITs, and more, but which area holds the most opportunity for long-term investors? In this segment of The Motley Fool's financials-focused show, Where the Money Is , banking...

Nanocoatings: The Global Market to 2020
PR Newswire - Thu Feb 13, 11:07AM CST
Research and Markets

Where the Money Is: February 12
Matt Koppenheffer and David Hanson, The Motley Fool - Motley Fool - Thu Feb 13, 8:57AM CST
Are you going to invest in peer-to-peer lending? Join Motley Fool analysts Matt Koppenheffer and David Hanson as they take a closer look at Charlie Munger's stock picks, play a game of Rank It!, and look at three insightful tweets. Advice from...

Platinum Underwriters Holdings, Ltd. Declares a Quarterly Dividend on Its Common Shares and Announces Its 2014 Annual General Meeting of Shareholders
PR Newswire - Tue Feb 11, 1:38PM CST
Platinum Underwriters Holdings, Ltd. (NYSE: PTP) announced today that the Board of Directors has declared a quarterly dividend of $0.08 per common share. The dividend is payable on March 31, 2014 to shareholders of record on March 3, 2014.

Platinum Underwriters Holdings, Ltd. Reports Financial Results For The Fourth Quarter And Year Ended December 31, 2013
PR Newswire - Tue Feb 04, 3:00PM CST
Platinum Underwriters Holdings, Ltd. (NYSE: PTP) today reported net income of $48.6 million and diluted earnings per common share of $1.71 for the quarter ended December 31, 2013 and net income of $223.3 million and diluted earnings per common share of $7.35 for the year ended December 31, 2013.

Everything Investors Need to Watch in the Week Ahead
David Hanson and Matt Koppenheffer, The Motley Fool - Motley Fool - Mon Feb 03, 5:00AM CST
Earnings season is in full-swing, and Prospect Capital and Fifth Street Finance are set to check in with investors this week. In this segment of The Motley Fool's financials-focused show, Where the Money Is , banking analysts Matt...

RLI Corp.: A Strong Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 31, 5:30PM CST
On Jan 30, Zacks Investment Research upgraded RLI Corp. (RLI) by a notch to a Zacks Rank #1 (Strong Buy).

Where the Money Is: January 31
Matt Koppenheffer and David Hanson, The Motley Fool - Motley Fool - Fri Jan 31, 2:51PM CST
We sit down with Million Dollar Portfolio advisor Ron Gross to chat about financials and a few other stocks on his radar. Join Motley Fool analysts Matt Koppenheffer and David Hanson as they discuss Amazon 's new idea, debate MasterCard 's...

Selective Insurance Beats on Q4 Earnings, Revs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 31, 1:50PM CST
Selective Insurance Group's fourth-quarter 2013 earnings of 45 cents a share bounced back from an operating loss of 4 cents a share in the prior-year quarter.

Q4 Earnings Beat at W.R. Berkley - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 29, 8:10AM CST
W.R. Berkley reported fourth-quarter 2013 earnings of 85 cents per share, 8 cents ahead of the Zacks Consensus Estimate and up 33% year over year.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JOYEE N01 Debuts Globally with First 2,000 Deliveries

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

HONGQI's EHS4 Launch in Europe: Bridging East and West

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Portillo's Faces Class Action: Investor Losses at Stake

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Investors Gear Up for Lennar Class Action Lawsuit

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Viking Ventures: Impacts of VK2735 on Obesity Examined

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...